CG Invites Co., Ltd.

Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.

083790 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 강서구 마곡중앙8로 38 마곡동, 강서구
Website:: https://cginvites.com/en
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized precision medicine. Leveraging its core competency in developing novel chemical and biological drugs—such as Acelex (osteoarthritis), Ivaltinostat (pancreatic cancer), and Camrelizumab (immuno-oncology)—the company has expanded its focus to several key areas. These include whole genome sequencing, contributing to large-scale bio-data projects; the development of personalized, mRNA-based cancer vaccines targeting tumor-specific neoantigens; and digital therapeutics (DTx), exemplified by its HealthOnG platform for diabetes management. The company's strategy is to innovate within the digital genome market by integrating its drug development expertise with cutting-edge genomic and digital health technologies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for CG Invites Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
2025-08-14 00:00	Interim Report 반기보고서 (2025.06)	Korean	1.8 MB
2025-08-14 00:00	Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서	Korean	34.7 KB

Automate Your Workflow. Get a real-time feed of all CG Invites Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CG Invites Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
StemRIM Inc. Developing regenerative medicines that use the body's own stem cells to treat intractable diseases.	Japan	4599
STENOCARE A/S Develops and distributes prescription medical cannabis oils in Northern Europe and Australia.	Denmark	STENO
ST PHARM CO., LTD. A global CDMO specializing in APIs and RNA therapeutics for the gene therapy market.	South Korea	237690
Sugentech, Inc. Develops advanced in-vitro diagnostic systems for hospitals, clinics, and at-home use.	South Korea	253840
SUHEUNG CO.,LTD. Global manufacturer of capsules and contract manufacturing for pharma/nutraceutical industries.	South Korea	008490
Sumitomo Pharma Co., Ltd. R&D pharma creating medicines for oncology, psychiatry & neurology, focusing on Japan & the US.	Japan	4506
SunBio, Inc. Develops biopharmaceuticals and devices like artificial blood using proprietary PEGylation technology.	South Korea	067370
Swedish Orphan Biovitrum Develops innovative therapies for rare diseases in haematology, immunology, and specialty care.	Sweden	SOBI
SymBio Pharmaceuticals Limited Acquires and commercializes specialty drugs for unmet needs in Japan and the Asia-Pacific region.	Japan	4582
SynAct Pharma Biotech developing oral therapies to resolve inflammation in diseases like rheumatoid arthritis.	Sweden	SYNACT